New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
15:37 EDTXOOM, BWLD, ULTI, AXS, EW, CHRW, AMP, HI, ATO, JKHY, CVD, MAC, CERN, AFL, GIMO, DV, HAIN, DATA, GNW, UNM, EQR, GILDNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Gilead Sciences (GILD), consensus 50c; AFLAC (AFL), consensus $1.39; Ameriprise Financial (AMP), consensus $1.81; Equity Residential (EQR), consensus 69c; Cerner (CERN), consensus 39c; CH Robinson Worldwide (CHRW), consensus 68c; Unum Group (UNM), consensus 84c; Macerich (MAC), consensus 92c; Edwards Lifesciences (EW), consensus 71c; Genworth Financial (GNW), consensus 30c; Covance (CVD), consensus 84c; AXIS Capital (AXS), consensus $1.47; Tableau Software (DATA), consensus 0c; Jack Henry & Associates (JKHY), consensus 60c; Ultimate Software (ULTI), consensus 41c; Hain Celestial (HAIN), consensus 87c; Atmos Energy (ATO), consensus 86c; Buffalo Wild Wings (BWLD), consensus $1.07; DeVry (DV), consensus 73c; Hillenbrand (HI), consensus 52c; Xoom (XOOM), consensus (1c); Gigamon (GIMO), consensus 12c.
News For GILD;AFL;AMP;EQR;CERN;CHRW;UNM;MAC;EW;GNW;CVD;AXS;DATA;JKHY;ULTI;HAIN;ATO;BWLD;DV;HI;XOOM;GIMO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
December 9, 2014
08:07 EDTEWEdwards Lifesciences price target raised to $155 from $135 at JMP Securities
Subscribe for More Information
07:45 EDTAMPGoldman to hold a conference
U.S. Financial Services Conference is being held in New York on December 9-10.
07:36 EDTEWEdwards Lifesciences TAVI growth reinforces bullish stance, says Canaccord
Subscribe for More Information
07:07 EDTEWEdwards price target raised to $151-$152 from $135-$140 at Wells Fargo
Wells Fargo increased its price target on Edwards Lifesciences as the firm believes that the company's roughly in-line 2015 guidance announced yesterday is conservative.The firm also notes that the company raised its long-term TAVR market assumption to over $3B in 2019. The firm keeps an Outperform rating on the shares.
December 8, 2014
17:01 EDTCHRWC.H. Robinson announces CFO transition
Subscribe for More Information
16:32 EDTHIHillenbrand divests Hyatt Regency Vancouver for about $123M
Subscribe for More Information
16:00 EDTGILDOptions Update; December 8, 2014
Subscribe for More Information
10:02 EDTGILDGilead presents follow-up data from Zydelig registrational studies
Subscribe for More Information
09:26 EDTULTIUltimate Software management to meet with Barrington
Subscribe for More Information
08:16 EDTEWEdwards Lifesciences announces investments in CardioKinetix
Edwards made a structured investment in CardioKinetix, a privately held medical device company pioneering a catheter-based treatment for heart failure. This transaction increases Edwards' existing minority interest in CardioKinetix and provides an option to purchase the remaining outstanding shares for a future payment, plus additional milestone payments based on future regulatory and reimbursement approvals. In the second investment, the company acquired intellectual property that broadens its transcatheter mitral valve development efforts. Additional details of both investments were not disclosed.
08:15 EDTEWEdwards Lifesciences sees FY15 EPS $3.90-$4.10, consensus $3.96
Subscribe for More Information
08:12 EDTEWEdwards Lifesciences backs FY14 EPS $3.33-$3.39, consensus $3.39
Subscribe for More Information
07:28 EDTDATAFBN Securities to hold a bus tour
Subscribe for More Information
07:08 EDTHAINHain Celestial price target raised to $129 from $117 at JPMorgan
JPMorgan raised its price target for Hain Celestial shares to $129 after meeting with management and keeps an Overweight rating on the name. The firm believes Hain continues to experience strong shipment and takeaway trends.
06:05 EDTEWEdwards Lifesciences to host investor meeting
Subscribe for More Information
December 5, 2014
16:14 EDTAXSAXIS Capital announces $750M share repurchase, increases dividend 7.4%
AXIS Capital Holdings announced that the company's board has authorized the repurchase up to $750M of the company’s common shares. The board has authorized the company to effect repurchases under this new plan in open market or privately negotiated transactions through December 31, 2016, depending on market conditions. This new repurchase authorization, effective January 1, 2015, will replace the existing authorization, which currently has approximately $268M in remaining authorization available through December 31, 2015. The company’s board also declared a quarterly dividend of 29c per common share, which represents an increase of 7.4%. The common dividend will be payable on January 15, 2015 to the shareholders of record at the close of business on December 31, 2014.
10:00 EDTEWOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Acorda Therapeutics (ACOR) initiated with a Neutral at Goldman... Builders FirstSource (BLDR) initiated with a Neutral at Sterne Agee... CSI Compressco (CCLP) initiated with a Buy at Stifel... California Resources Corp. (CRC) initiated with a Market Perform at Raymond James... Castlight Health (CSLT) initiated with an Equal Weight at First Analysis... DCP Midstream (DPM) initiated with a Buy at MLV & Co.... DSP Group (DSPG) initiated with an Outperform at Imperial Capital... Edwards Lifesciences (EW) initiated with an Outperform at Bernstein... EnLink Midstream (ENLK) initiated with a Buy at MLV & Co.... Facebook (FB) initiated with a Buy at MKM Partners... FireEye (FEYE) initiated with a Market Perform at JMP Securities... FleetCor (FLT) initiated with a Buy at Deutsche Bank... Imperva (IMPV) initiated with a Buy at Nomura... Keryx (KERX) initiated with an Outperform at Cowen... Knowles (KN) initiated with a Market Perform at FBR Capital... Marlin Midstream (FISH) initiated with a Buy at MLV & Co.... Paragon Offshore (PGN) initiated with a Sector Perform at Iberia... PepsiCo (PEP) initiated with a Buy at Evercore ISI... Proofpoint (PFPT) initiated with a Buy at Nomura... Relypsa (RLYP) initiated with an Outperform at Oppenheimer... Rocket Fuel (FUEL) initiated with a Sell at Maxim... Sprouts Farmers Markets (SFM) initiated with an Underperform at Longbow... Summit Midstream (SMLP) initiated with a Buy at MLV & Co.... TubeMogul (TUBE) initiated with a Buy at Maxim... Western Gas Partners (WES) initiated with a Buy at MLV & Co.
09:36 EDTGILDActive equity options trading
Subscribe for More Information
07:37 EDTGILDGilead price target raised to $121 from $110 at JPMorgan
JPMorgan raised its price target for Gilead shares to $121 saying the company's potential cash flow generation is "immense" and provides "significant strategic flexibility." The firm estimates Gilead can generate more than $30B in cash in the next two years and $80B-plus over the next five years. It keeps an Overweight rating on the stock.
07:13 EDTEWEdwards Lifesciences initiated with an Outperform at Bernstein
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use